BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24959954)

  • 1. New advances in treating thrombotic diseases.
    Schumacher WA; Wang X; Wong PC
    Drug Discov Today; 2014 Sep; 19(9):1433-4. PubMed ID: 24959954
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor IXa as a target for anticoagulation in thrombotic disorders and conditions.
    Smiley DA; Becker RC
    Drug Discov Today; 2014 Sep; 19(9):1445-53. PubMed ID: 24998782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin and low molecular weight heparin in thrombosis and beyond.
    Mousa SA
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical causes and treatment of the thrombotic storm.
    Ortel TL; Kitchens CS; Erkan D; Brandão LR; Hahn S; James AH; Kulkarni R; Manco-Johnson MJ; Pericak-Vance M; Vance J
    Expert Rev Hematol; 2012 Dec; 5(6):653-9. PubMed ID: 23216595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anticoagulants: an update.
    Crowther M; Weitz JI
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):743-9. PubMed ID: 16170892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment for thrombotic diseases.
    Cazenave JP; Wiesel ML; Hemmendinger S
    Agents Actions Suppl; 1984; 15():24-49. PubMed ID: 6091424
    [No Abstract]   [Full Text] [Related]  

  • 8. The application of proteomics technology to thrombosis research: the identification of potential therapeutic targets in cardiovascular disease.
    Howes JM; Keen JN; Findlay JB; Carter AM
    Diab Vasc Dis Res; 2008 Sep; 5(3):205-12. PubMed ID: 18777494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pharmacologic strategies for arterial and venous thromboembolism.
    Agnelli G
    Haematologica; 2001 Nov; 86(11 Suppl 2):58. PubMed ID: 11926780
    [No Abstract]   [Full Text] [Related]  

  • 10. Changing the scope of preventative and therapeutic approaches in atherothrombosis.
    Peter K; Lip GY
    Thromb Haemost; 2010 Mar; 103(3):487-8. PubMed ID: 20135057
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor XII: a drug target for safe interference with thrombosis and inflammation.
    Kenne E; Renné T
    Drug Discov Today; 2014 Sep; 19(9):1459-64. PubMed ID: 24993156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Where to look for progress in antithrombotic treatments?].
    Samama MM
    Rev Prat; 1999 Oct; 49(15):1664-8. PubMed ID: 10581998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic "rebound" after withdrawal of oral anticoagulants.
    Drug Ther Bull; 1966 Nov; 4(23):92. PubMed ID: 5979908
    [No Abstract]   [Full Text] [Related]  

  • 14. [On fibrinolytic therapy of intravascular thrombosis (review of the literature)].
    Gritsiuk AI
    Ter Arkh; 1967 May; 39(5):12-9. PubMed ID: 4237762
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulant therapy.
    Lovell RR
    J Postgrad Med; 1974 Jul; 20(3):118-23. PubMed ID: 4457625
    [No Abstract]   [Full Text] [Related]  

  • 16. [New medical anticoagulants].
    Choussat R; Montalescot G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):985-95. PubMed ID: 10907447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.
    Hettiarachchi RJ; Smorenburg SM; Ginsberg J; Levine M; Prins MH; Büller HR
    Thromb Haemost; 1999 Aug; 82(2):947-52. PubMed ID: 10605808
    [No Abstract]   [Full Text] [Related]  

  • 18. Low molecular weight heparins. A pharmacologic overview.
    Hillis LB
    Adv Nurse Pract; 1997 Oct; 5(10):53-6. PubMed ID: 9459986
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rheologic modifications induced by heparin therapy. Capillary blood viscosity, erythrocyte deformability, aggregation index].
    Achilli E; Cortinovis A; Ardemagni P; Crippa A
    Minerva Cardioangiol; 1999 Apr; 47(4):95-119. PubMed ID: 10416313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Some recent advances in the anticoagulant and fibrinolytic therapy of thrombosis].
    Samama M
    Angeiologie; 1967; 20():Suppl:54-8. PubMed ID: 5621508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.